Early detection and treatment of Alzheimer's makes a difference

A Finnish project (ALSOVA) has been following 240 patient-caregiver pairs, where the patient had very mild or mild Alzheimer's disease at the beginning of the study and had a family caregiver. A three-year follow-up of 115 patients has found that those diagnosed and treated very early were able to manage their everyday activities longer and suffered from less psychological and behavioral symptoms, compared to those diagnosed later.

http://www.eurekalert.org/pub_releases/2013-07/uoef-eda071813.php

[3574] Hallikainen, I., Hänninen T., Fraunberg M., Hongisto K., Välimäki T., Hiltunen A., et al.
(2013).  Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
International Psychogeriatrics. 25(Special Issue 08), 1335 - 1344.

Related News

For the first time in 27 years, clinical diagnostic criteria for Alzheimer's disease dementia have been revised, and research guidelines updated. They mark a major change in how experts think about and study Alzheimer's disease.

A survey of more than 100 studies involving PIB-PET, a diagnostic tool that involves injecting a radiotracer called

A new test has been developed that measures amyloid-beta oligomers in the cerebrospinal fluid, promising a reliable means of early diagnosis.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news